XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net sales $ 1,203,844 $ 733,771
Cost of goods sold 363,987 298,115
Gross profit 839,857 435,656
Operating expenses:    
Research and development 498,965 1,523,114
Selling, general and administrative 5,724,588 6,560,726
Restructuring and other severance related charges 365,000
Total operating expenses 6,223,553 8,448,840
Loss from operations (5,383,696) (8,013,184)
Other (income)/expense    
Interest and other income (3,386) (62,976)
Other expense 3,522 9,141
Total other (income)/expense 136 (53,835)
Net loss $ (5,383,832) $ (7,959,349)
Net loss per share of common stock - Basic and Diluted (see Note 12) $ (0.11) $ (0.27)
Weighted average common shares outstanding - Basic and Diluted (see Note 12) 47,653,202 29,774,226